首页> 外文期刊>Journal of Surgical Case Reports >Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis
【24h】

Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis

机译:静脉内免疫球蛋白用于治疗部分难治性慢性溃疡性结肠炎的大肠切除术后伴末端回肠造口术治疗重症围手术期坏死性脓皮性坏疽

获取原文
       

摘要

Peristomal pyoderma gangrenosum (PPG) is a rare subtype of pyoderma gangrenosum that is characterized by painful, necrotic ulcerations occurring in the area surrounding an abdominal stoma. PPG is typically seen in younger patients with active inflammatory bowel disease. The etiology and pathogenesis is largely unknown and risk factors are not well defined. Therapy typically involves a combination of aggressive local wound care and systemic medications. Diagnosis and management of PPG can be difficult and data on treatment are limited. We present a case of severe postoperative peristomal recalcitrant to conventional therapy successfully treated with intravenous immune globulin.
机译:坏疽性脓皮病性脓皮病(PPG)是坏疽性脓皮病的一种亚型,其特征是在腹部气孔周围区域发生疼痛性坏死性溃疡。 PPG通常见于患有活动性炎症性肠病的年轻患者。病因和发病机制很大程度上未知,危险因素也没有明确定义。治疗通常涉及积极的局部伤口护理和全身性药物治疗。 PPG的诊断和管理可能很困难,并且治疗数据有限。我们提出了一例严重的术后肠壁顽固顽固症患者成功接受静脉免疫球蛋白治疗的常规治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号